ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
-1.19%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$382M
AUM Growth
+$382M
(-15%)
Cap. Flow
-$47.9M
Cap. Flow
% of AUM
-12.55%
Top 10 Holdings %
Top 10 Hldgs %
31.25%
Holding
87
New
11
Increased
25
Reduced
24
Closed
19
Top Buys
| 1 |
Grocery Outlet
GO
|
$7.34M |
| 2 |
Q2 Holdings
QTWO
|
$5.91M |
| 3 |
Repligen
RGEN
|
$5.37M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$5.34M |
| 5 |
AZUL
Azul
AZUL
|
$5.19M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$14M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$9.31M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$7.05M |
| 4 |
Marriott Vacations Worldwide
VAC
|
$5.59M |
| 5 |
CrowdStrike
CRWD
|
$5.26M |
Sector Composition
| 1 | Healthcare | 29.73% |
| 2 | Technology | 21.78% |
| 3 | Communication Services | 16.27% |
| 4 | Consumer Discretionary | 13.87% |
| 5 | Materials | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ascendis Pharma
ASND
$11.8B
| $2.41M | 0.51% |
25,000
-16,000
| -39% | -$1.54M |
|
52
Krystal Biotech
KRYS
$4.27B
| $2.03M | 0.43% |
+58,319
| New | +$2.03M |
|
53
Galapagos
GLPG
$2.07B
| $1.83M | 0.39% |
12,000
-7,000
| -37% | -$1.07M |
|
|
MRTX
54
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.79M | 0.38% |
23,000
-24,000
| -51% | -$1.87M |
|
55
Edwards Lifesciences
EW
$47.8B
| $1.76M | 0.37% |
+8,000
| New | +$1.76M |
|
|
ZGNX
56
DELISTED
Zogenix, Inc.
ZGNX
| $1.72M | 0.36% |
43,000
+3,000
| +8% | +$120K |
|
57
New York Times
NYT
$9.74B
| $1.54M | 0.32% |
54,000
-96,000
| -64% | -$2.73M |
|
58
Zoom
ZM
$24.4B
| $1.52M | 0.32% |
20,000
-17,000
| -46% | -$1.29M |
|
|
JWN
59
DELISTED
Nordstrom
JWN
| $1.35M | 0.28% |
+40,000
| New | +$1.35M |
|
60
PTC Therapeutics
PTCT
$3.92B
| $853K | 0.18% |
25,208
-49,792
| -66% | -$1.68M |
|
|
61
Marriott Vacations Worldwide
VAC
$2.7B
| $207K | 0.04% |
2,000
-54,000
| -96% | -$5.59M |
|
|
GOOS
62
Canada Goose Holdings
GOOS
$1.26B
| – | – |
-100,000
| Closed | -$3.87M |
|
63
Madrigal Pharmaceuticals
MDGL
$9.76B
| – | – |
0
| – | – |
|
64
Molina Healthcare
MOH
$9.8B
| – | – |
-12,000
| Closed | -$1.72M |
|
65
Adverum Biotechnologies
ADVM
$64.6M
| – | – |
-369,000
| Closed | -$4.39M |
|
|
ALLK
66
DELISTED
Allakos
ALLK
| – | – |
0
| – | – |
|
67
Ashland
ASH
$2.57B
| – | – |
-38,000
| Closed | -$3.04M |
|
68
Anterix
ATEX
$445M
| – | – |
-38,000
| Closed | -$1.79M |
|
69
Brink's
BCO
$4.67B
| – | – |
-47,000
| Closed | -$3.82M |
|
|
70
CrowdStrike
CRWD
$106B
| – | – |
-77,000
| Closed | -$5.26M |
|
71
Guardant Health
GH
$8.41B
| – | – |
-47,000
| Closed | -$4.06M |
|
72
Iovance Biotherapeutics
IOVA
$807M
| – | – |
-185,000
| Closed | -$4.54M |
|
73
iShares Russell 2000 ETF
IWM
$67B
| – | – |
0
| – | – |
|
74
McKesson
MCK
$85.4B
| – | – |
0
| – | – |
|
75
Invesco QQQ Trust
QQQ
$364B
| – | – |
0
| – | – |
|